Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Microbiome-based Therapy
Therapeutic Area : Gastroenterology
Study Phase : Discovery
Sponsor : Ferring Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : Under the collaboration, Ferring will get exclusive rights to develop, manufacture and commercialise next generation microbiome-based therapeutics within the field of gastroenterology arising out of the collaboration.
Brand Name : Undisclosed
Molecule Type : Large molecule
Upfront Cash : Undisclosed
December 11, 2023
Lead Product(s) : Microbiome-based Therapy
Therapeutic Area : Gastroenterology
Highest Development Status : Discovery
Sponsor : Ferring Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Licensing Agreement
LOOKING FOR A SUPPLIER?